INmune Bio, Inc.

INMB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$20,922$35,848$52,153$74,810
Short-Term Investments$0$0$0$0
Receivables$1,409$2,442$8,461$5,504
Inventory$0$0$34-$5,504
Other Curr. Assets$331$1,652$4,027$7,796
Total Curr. Assets$22,662$39,942$64,675$82,606
Property Plant & Equip (Net)$307$414$507$726
Goodwill$0$0$0$0
Intangibles$16,514$16,514$16,514$16,514
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$79$131$99$99
Total NC Assets$16,900$17,059$17,120$17,339
Other Assets$0$0$0$0
Total Assets$39,562$57,001$81,795$99,945
Liabilities
Payables$6,564$7,901$5,206$3,803
Short-Term Debt$140$10,040$5,087$144
Tax Payable$0$0$0$0
Deferred Revenue$0$0$616$474
Other Curr. Liab.$517$524$9-$62
Total Curr. Liab.$7,221$18,465$10,918$4,359
LT Debt$244$397$10,223$15,162
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$550$199
Total NC Liab.$244$397$10,773$15,361
Other Liabilities$0$0$0$0
Cap. Leases$384$516$613$776
Total Liabilities$7,465$18,862$21,691$19,720
Equity
Pref Stock$0$0$0$0
Common Stock$22$817$18$18
Retained Earnings-$163,104-$121,022-$91,014-$63,715
AOCI-$575-$799-$699$1
Other Equity$195,754$159,143$151,799$143,921
Total Equity$32,097$38,139$60,104$80,225
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$39,562$57,001$81,795$99,945
Net Debt-$20,538-$25,411-$36,843-$59,504